vers la météo de la validation par utilisateur

Ingenuity307

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 81 - PMID ?

In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :
Analyse 0 
             +-------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                           
             |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                                           
             |                 |              +--------------------------APPOS-------------------------+                    +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
             |                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       +MOD_A+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (heart,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,heart)
SUBJ:V-N (decrease,administration)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 1 
             +-------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                           
             |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                                           
             |                 |              +--------------------------APPOS-------------------------+                    +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
             |                 |              |        +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       +MOD_A+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (heart,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,heart)
SUBJ:V-N (decrease,administration)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 2 
             +-------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                           
             |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                                           
             |                 +---------------------------------APPOS---------------------------------+                    +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
             |                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       +MOD_A+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (heart,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,heart)
SUBJ:V-N (decrease,administration)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 3 
             +-------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                           
             |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                                           
             |                 +---------------------------------APPOS---------------------------------+                    +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
             |                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       +MOD_A+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (heart,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,heart)
SUBJ:V-N (decrease,administration)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 4 
       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                                                           
       |     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                                           
       |     |                                +--------------------------APPOS-------------------------+                    +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       |     +------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |     |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
APPOS (heart,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,heart)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 5 
       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                                                           
       |     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                                           
       |     |                                +--------------------------APPOS-------------------------+                    +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       |     +------APPOS------+              |        +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |     |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
APPOS (heart,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,heart)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 6 
       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                                                           
       |     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                                           
       |     |                 +---------------------------------APPOS---------------------------------+                    +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       |     +------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |     |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
APPOS (heart,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,heart)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 7 
       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                                                           
       |     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                                           
       |     |                 +---------------------------------APPOS---------------------------------+                    +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       |     +------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |     |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
APPOS (heart,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,period)
OBJ:V-N (with,mg/kg/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,heart)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 8 
             +-------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                           
             |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                                           
             |                 |                       +--------------------OBJ:V-N--------------------+                    |                                                           
             |                 |                       |                      +------------COMP:N-N(of)------------+        +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
             |                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       +MOD_A+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (heart,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,heart)
SUBJ:V-N (decrease,administration)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 9 
             +-------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                           
             |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                                           
             |                 |                       +--------------------OBJ:V-N--------------------+                    |                                                           
             |                 |                       |                      +------------COMP:N-N(of)------------+        +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
             |                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       +MOD_A+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (heart,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,heart)
SUBJ:V-N (decrease,administration)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 10 
             +-------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                           
             |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                                           
             |                 |                       +--------------------OBJ:V-N--------------------+                    |                                                           
             |                 |                       |                      +------------COMP:N-N(of)------------+        +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
             |                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       +MOD_A+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (heart,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,heart)
SUBJ:V-N (decrease,administration)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 11 
             +-------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                           
             |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                                           
             |                 |                       +--------------------OBJ:V-N--------------------+                    |                                                           
             |                 |                       |                      +------------COMP:N-N(of)------------+        +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
             |                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       +MOD_A+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (heart,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,heart)
SUBJ:V-N (decrease,administration)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 12 
       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                                                           
       |     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                                           
       |     |                                         +--------------------OBJ:V-N--------------------+                    |                                                           
       |     |                                         |                      +------------COMP:N-N(of)------------+        +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       |     +------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |     |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
APPOS (heart,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,heart)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 13 
       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                                                           
       |     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                                           
       |     |                                         +--------------------OBJ:V-N--------------------+                    |                                                           
       |     |                                         |                      +------------COMP:N-N(of)------------+        +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       |     +------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |     |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
APPOS (heart,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,heart)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 14 
       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                                                           
       |     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                                           
       |     |                                         +--------------------OBJ:V-N--------------------+                    |                                                           
       |     |                                         |                      +------------COMP:N-N(of)------------+        +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       |     +------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |     |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
APPOS (heart,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,heart)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 15 
       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                                                           
       |     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                                           
       |     |                                         +--------------------OBJ:V-N--------------------+                    |                                                           
       |     |                                         |                      +------------COMP:N-N(of)------------+        +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       |     +------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |     |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
APPOS (heart,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,heart)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 16 
             +-------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                           
             |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                                           
             |                 |                       +--------------------OBJ:V-N--------------------+                    +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
             |                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       +MOD_A+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (heart,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,heart)
SUBJ:V-N (decrease,administration)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 17 
             +-------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                           
             |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                                           
             |                 |                       +--------------------OBJ:V-N--------------------+                    +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
             |                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       +MOD_A+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (heart,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,heart)
SUBJ:V-N (decrease,administration)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 18 
             +-------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                           
             |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                                           
             |                 |                       +--------------------OBJ:V-N--------------------+                    +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
             |                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       +MOD_A+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (heart,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,heart)
SUBJ:V-N (decrease,administration)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 19 
             +-------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                           
             |                 +------------------------------------------SUBJ:V-N------------------------------------------+                                                           
             |                 |                       +--------------------OBJ:V-N--------------------+                    +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
             |                 |                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       +MOD_A+       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (heart,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,heart)
SUBJ:V-N (decrease,administration)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 20 
       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                                                           
       |     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                                           
       |     |                                         +--------------------OBJ:V-N--------------------+                    +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       |     +------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |     |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
APPOS (heart,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,heart)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 21 
       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                                                           
       |     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                                           
       |     |                                         +--------------------OBJ:V-N--------------------+                    +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       |     +------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |     |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
APPOS (heart,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,heart)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 22 
       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                                                           
       |     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                                           
       |     |                                         +--------------------OBJ:V-N--------------------+                    +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       |     +------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |     |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
APPOS (heart,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,heart)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 23 
       +----------------------------------------------------COMP:V-N(In)----------------------------------------------------+                                                           
       |     +---------------------------------------------------SUBJ:V-N---------------------------------------------------+                                                           
       |     |                                         +--------------------OBJ:V-N--------------------+                    +-----------OBJ:V-N----------+-------COMP:N-N(of)-------+   
       |     +------APPOS------+                       +--------OBJ:V-N-------+                        +COMP:N-N(of+        +--COMP:V-N(by)--+           |           +-MOD_ATT:N-ADJ+   
       |     |       +MOD_ATT:N+-COMP:N-N(of)-+        |       +COMP:N-+      |               +MOD_ATT:+       +MOD+        |           +MOD_+           |           |       +MOD_AT+   
       |     |       |         |              |        |       |       |      |               |        |       |   |        |           |    |           |           |       |      |   
 In __SP__ heart , oral administration of __NODE__ ( with a dosage of 100 mg/kg/day and a treatment period of 10 days ) decreases ( by 98 percent ) expression of __SP__ __NODE__ mRNA .
APPOS (heart,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (decrease,__SP__)
SUBJ:V-N (decrease,heart)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)